Rx ACCESS Act
- Bill Number
- S. 4106
- Origin Chamber
- Senate
- Congress
- 119th Congress, Session 2
- Policy Area
- Armed Forces and National Security
- Status
- Introduced
- Latest Action
- 2026-04-13: Star Print ordered on the bill.
- Last Updated
- 2026-06-17T11:03:26Z
AI-Generated Summary
Purpose
The Rx Access, Choice, Cost Equity, and Supply Stability Act (Rx ACCESS Act), S. 4106, aims to enhance access to prescription medications for eligible beneficiaries under the TRICARE pharmacy benefits program. It focuses on giving beneficiaries more choices in how they receive refills, ensuring fair reimbursement for retail pharmacies, and increasing transparency through audits and reporting.
Key Provisions
- Beneficiary Choice in Refills: Starting October 1, 2026, eligible covered beneficiaries (such as active-duty service members, retirees, and their families) can choose any approved method to receive refills for non-generic (brand-name) maintenance medications, including mail-order or retail pharmacy options. This builds on existing rules that began in 2015 for generic medications.
- Reimbursement Standards for Pharmacies: Pharmacy benefit managers (companies that handle TRICARE's drug benefits) must reimburse retail pharmacies at least the actual cost of acquiring the drug from a wholesaler (or a national average cost benchmark from Medicare data) plus a professional dispensing fee equivalent to what the state pays under Medicaid for filling prescriptions.
- Prohibition on Fees: Pharmacy benefit managers cannot charge retail pharmacies additional fees, such as point-of-sale charges, retroactive adjustments, or hidden costs.
- Independent Audits: The U.S. Government Accountability Office (GAO, led by the Comptroller General) must conduct annual audits of reimbursement rates, price concessions, and the adequacy of the TRICARE pharmacy network. Audits will assess factors like geographic access (especially in rural or underserved areas), continuity of care, and whether beneficiary choices align with preferences. Results will be reported to the Senate and House Armed Services Committees.
- Implementation Report: The Secretary of Defense must submit a plan to congressional defense committees within 90 days of enactment detailing how these changes will be put into effect.
Significant Changes to Existing Law
- Amends Section 1074g of Title 10, U.S. Code (which governs TRICARE pharmacy benefits) by expanding beneficiary refill options beyond generics to include non-generic maintenance drugs after October 1, 2026, removing prior limitations.
- Introduces new mandatory reimbursement formulas and fee prohibitions, which were not previously specified, to standardize and protect payments to retail pharmacies.
- Adds a dedicated subsection (i) for pharmacy benefit manager standards and requires annual GAO audits, shifting from less formalized oversight to structured, independent reviews. This also redesignates existing subsections for clarity.
Potential Impacts
- On Beneficiaries: Improves flexibility in obtaining medications, potentially reducing barriers to care, especially for those in remote or rural areas, and supports personal preferences for refill methods.
- On Pharmacies and Providers: Ensures more predictable and adequate payments, which could encourage greater participation in the TRICARE network and reduce pharmacy closures or reduced services in underserved regions.
- On Government Agencies: Increases administrative burdens on the Department of Defense (DoD) for contract oversight and data provision to the GAO, but enhances program transparency and accountability. No direct international relations impacts, as it focuses on domestic military health benefits.
- Broader Effects: May stabilize medication supply chains for military families by promoting fair pricing, potentially lowering overall program costs through better network efficiency, though initial implementation could require adjustments.
Main Stakeholders Affected
- TRICARE Beneficiaries: Active-duty personnel, retirees, and dependents who rely on the program for prescription access.
- Retail Pharmacies: Independent and chain pharmacies that dispense TRICARE-covered drugs, benefiting from fairer reimbursements.
- Pharmacy Benefit Managers: Contractors (e.g., private firms administering TRICARE benefits) required to meet new standards and provide audit data.
- Department of Defense: Oversees TRICARE implementation, including contract updates and reporting to Congress.
- Congressional Committees: Senate and House Armed Services Committees receive audits and implementation plans, influencing future oversight.
- Government Accountability Office: Conducts required audits to ensure compliance.
Notable Legal, Constitutional, or Political Implications
- Legal: Strengthens administrative requirements under federal procurement and health benefits laws (e.g., linking to Medicaid dispensing fees for consistency across programs). It promotes fairness in contractor reimbursements without altering core TRICARE eligibility or coverage.
- Constitutional: No apparent challenges; the bill operates within Congress's authority over military benefits (Article I, Section 8) and does not infringe on individual rights or state powers beyond referencing state Medicaid rates.
- Political: Bipartisan sponsorship (by Senators Cotton and Kaine) highlights cross-party support for military health care improvements. It addresses concerns about pharmacy access and costs, potentially setting precedents for similar reforms in other federal health programs like Medicare, but focuses narrowly on TRICARE without broader fiscal mandates.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (4)
Sen. Kaine, Tim [D-VA], Sen. Capito, Shelley Moore [R-WV], Sen. King, Angus S., Jr. [I-ME], Sen. Rounds, Mike [R-SD]
Recent Actions
- 2026-04-13: Star Print ordered on the bill.
- 2026-03-17: Read twice and referred to the Committee on Armed Services.
- 2026-03-17: Introduced in Senate
Bill Versions
- Rx Access, Choice, Cost Equity, and Supply Stability Act — issued 2026-03-17 — PDF (5 pages)